Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome
Open Access
- 9 January 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (1) , 67-74
- https://doi.org/10.1212/wnl.56.1.67
Abstract
Background: Miller Fisher syndrome (MFS), a variant of the Guillain-Barré syndrome, is associated with the presence of neuromuscular blocking antibodies, some of which may be directed at the ganglioside GQ1b. Materials and Methods: The authors investigated the in vitro effects of serum and purified immunoglobulin (Ig) G in a total of 11 patients with typical MFS during active disease, and in three of those patients after recovery. From one patient’s serum, we prepared an IgG fraction enriched in anti-GQ1b antibodies by affinity chromatography. For combined pre- and postsynaptic analysis, endplate currents were recorded by a perfused macro-patch clamp electrode. Postsynaptic nicotinic acetylcholine receptor channels were investigated by an outside-out patch clamp technique in cultured mouse myotubes. Results: AllMFS-sera depressed evoked quantal release and reduced the amplitude of postsynaptic currents. Five of the 11 sera were additionally examined by outside-out patch clamp analysis and caused a concentration-dependent and reversible decrease in acetylcholine-induced currents. The time course of activation and desensitization of nicotinic acetylcholine receptor channels was not altered by MFS-IgG. Nine patients (82 %) were positive for anti-GQ1b antibodies in ELISA and dot–blot. The enriched anti-GQ1b antibody fraction had a similar effect as whole serum. After recovery from MFS, blocking activity was lost and sera originally positive for anti-GQ1b antibodies became negative. Conclusion: Circulating IgG antibodies induce both pre- and postsynaptic blockade and may play a pathogenic role in acute MFS.Keywords
This publication has 42 references indexed in Scilit:
- Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparationsJournal of Clinical Investigation, 1999
- Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channelsAnnals of Neurology, 1998
- Open Channel Block by Physostigmine and Procaine in Embryonic‐like Nicotinic Receptors of Mouse MuscleEuropean Journal of Neuroscience, 1996
- Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of miceNeuroscience Letters, 1995
- Acetylcholine release in myasthenia gravis: Regulation at single end‐plate levelAnnals of Neurology, 1995
- Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter releaseThe Lancet, 1994
- A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1Zeitschrift für Neurologie, 1994
- Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor FunctionaAnnals of the New York Academy of Sciences, 1993
- Measurement and significance of antibodies against GM1 ganglioside Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.Journal of Neuroimmunology, 1989
- Myasthenia GravisNew England Journal of Medicine, 1977